{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T00:03:46Z","timestamp":1648944226564},"reference-count":42,"publisher":"Akademiai Kiado Zrt.","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orvosi Hetilap"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:p> Cancer-related hypercalcaemia is one of the most common life-threatening metabolic disorders. It occurs in 20% to 30% of patients with cancer during the course of the disease, which depends on tumour type, too. There are two types of cancer-related hypercalcemia: humoral hypercalcemia and local osteolytic hypercalcaemia. Malignant hypercalcaemia is mediated by several circulating factors secreted by malignant cells. The biological actions of these factors are primarily stimulation of osteoclasts to resorb bone and, secondly, stimulation of calcium reabsorption at the renal tubules resulting in an elevation of serum calcium level. Diagnosis of hypercalcaemia is relatively difficult due to the non-specific clinical signs as well as the underlying malignancy and the side-effects of palliative medical treatment. Consequently, cancer-related hypercalcaemia is underdiagnosed quite often. Unrecognised malignant hypercalcaemia can lead to death. Nowadays 90% of hypercalcaemia can be treated with administration of intravenous saline containing fluids and bisphosphonates. Literature data suggest that hypercalcaemia is treated in less than 40% of hospitalized patients properly due to diagnostic errors and mismanagement. Orv. Hetil., 2013, 154, 1367\u20131373. <\/jats:p>","DOI":"10.1556\/oh.2013.29665","type":"journal-article","created":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T01:00:47Z","timestamp":1377478847000},"page":"1367-1373","source":"Crossref","is-referenced-by-count":3,"title":["The significance of early diagnosis of cancer-related hypercalcaemia"],"prefix":"10.1556","volume":"154","author":[{"given":"Ildik\u00f3","family":"Radv\u00e1nyi","sequence":"first","affiliation":[{"name":"P\u00e9csi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar Csal\u00e1dorvostani Int\u00e9zet, Palliat\u00edv Tansz\u00e9k P\u00e9cs R\u00e1k\u00f3czi u. 2. 7623"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1gnes","family":"Csik\u00f3s","sequence":"additional","affiliation":[{"name":"P\u00e9csi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar Csal\u00e1dorvostani Int\u00e9zet, Palliat\u00edv Tansz\u00e9k P\u00e9cs R\u00e1k\u00f3czi u. 2. 7623"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e1ndor","family":"Balogh","sequence":"additional","affiliation":[{"name":"P\u00e9csi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar Csal\u00e1dorvostani Int\u00e9zet, Palliat\u00edv Tansz\u00e9k P\u00e9cs R\u00e1k\u00f3czi u. 2. 7623"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"atypb1","first-page":"436","volume":"45","year":"1998","journal-title":"Dan. Med. Bull."},{"key":"atypb2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-2796.2001.00859.x","volume":"250","year":"2001","journal-title":"J. Intern. Med."},{"key":"atypb3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","volume":"352","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"atypb4","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1097-0142(19930215)71:4<1309::AID-CNCR2820710423>3.0.CO;2-M","volume":"71","year":"1993","journal-title":"Cancer"},{"key":"atypb5","first-page":"1268","volume":"78","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"atypb6","volume-title":"Palliative medicine","year":"2009"},{"key":"atypb7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.3616618","volume":"237","year":"1987","journal-title":"Science"},{"key":"atypb8","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.3685994","volume":"238","year":"1987","journal-title":"Science"},{"key":"atypb9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0748-7983(98)91589-X","volume":"24","year":"1998","journal-title":"Eur. J. Surg. Oncol."},{"key":"atypb10","first-page":"1551","volume":"29","year":"2009","journal-title":"Anticancer Research"},{"key":"atypb11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1677\/erc.1.00543","volume":"12","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"atypb12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-111-10-807","volume":"111","year":"1989","journal-title":"Ann. Intern. Med."},{"key":"atypb13","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199004193221603","volume":"322","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"atypb14","first-page":"465","volume":"71","year":"1994","journal-title":"Lab. Invest."},{"key":"atypb15","first-page":"S4","volume":"58","year":"2001","journal-title":"Am. J. Health Syst. Pharm."},{"key":"atypb16","volume-title":"Disorders of calcium homeostasis. Fundamentals of palliative treatment. [A kalciumh\u00e1ztart\u00e1s zavarai. A palliat\u00edv ell\u00e1t\u00e1s alapjai.]","year":"2009"},{"key":"atypb18","first-page":"16","volume":"17","year":"1990","journal-title":"Semin. Oncol."},{"key":"atypb19","first-page":"153","volume":"12","year":"1989","journal-title":"Cancer Nurs."},{"key":"atypb20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7326\/0003-4819-149-4-200808190-00007","volume":"149","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.2174\/1381612033453640"},{"key":"atypb22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/1566524023362104","volume":"2","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"atypb23","first-page":"195","volume":"17","year":"2007","journal-title":"LAM"},{"key":"atypb24","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","year":"2006"},{"key":"atypb25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2125.1992.tb04101.x","volume":"34","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"key":"atypb26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1200\/JCO.2001.19.2.558","volume":"19","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"atypb27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/sonc.2002.34873","volume":"29","year":"2002","journal-title":"Semin. Oncol."},{"key":"atypb28","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/cncr.11701","volume":"98","year":"2003","journal-title":"Cancer"},{"key":"atypb29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/bjc.1997.48","volume":"75","year":"1997","journal-title":"Br. J. Cancer"},{"key":"atypb30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.1996.14.1.268","volume":"14","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"atypb31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00520-003-0477-1","volume":"11","year":"2003","journal-title":"Support. Care Cancer"},{"key":"atypb32","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/annonc\/mdg401","volume":"14","year":"2003","journal-title":"Ann. Oncol."},{"key":"atypb33","first-page":"3607","volume":"25","year":"2005","journal-title":"Anticancer Res."},{"key":"atypb34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-95-2-192","volume":"95","year":"1981","journal-title":"Ann. Intern. Med."},{"key":"atypb35","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1007\/BF02553290","volume":"46","year":"1990","journal-title":"Calcif. Tissue Int."},{"key":"atypb36","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/archinte.1990.00390210095021","volume":"150","year":"1990","journal-title":"Arch. Intern. Med."},{"key":"atypb37","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1172\/JCI111353","volume":"73","year":"1984","journal-title":"J. Clin. Invest."},{"key":"atypb38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.7326\/0003-4819-108-5-669","volume":"108","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"atypb39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00130404-200601000-00009","volume":"12","year":"2006","journal-title":"Cancer J."},{"key":"atypb40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000188907","volume":"72","year":"1996","journal-title":"Nephron"},{"key":"atypb41","first-page":"345","volume":"5","year":"2010","journal-title":"Clin. Interv. Aging"},{"key":"atypb42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/er.2007-0014","volume":"29","year":"2008","journal-title":"Endocr. Rev."},{"key":"atypb43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/BOR.0b013e32832ca41c","volume":"21","year":"2009","journal-title":"Curr. Opin. Rheumatol."}],"container-title":["Orvosi Hetilap"],"original-title":[],"language":"hu","link":[{"URL":"https:\/\/www.akademiai.com\/doi\/pdf\/10.1556\/OH.2013.29665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T09:53:51Z","timestamp":1590141231000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/oh.2013.29665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":42,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1556\/OH.2013.29665"],"URL":"https:\/\/doi.org\/10.1556\/oh.2013.29665","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}